94 related articles for article (PubMed ID: 15834176)
1. [Sentinel nodes identification efficacy prognostic criteria in breast cancer].
Kokhreidze ID; Nemsadze GG; Gersamiia GK; Dzagnidze GB; Dzhandzhaliia MT
Georgian Med News; 2005 Feb; (119):31-4. PubMed ID: 15834176
[TBL] [Abstract][Full Text] [Related]
2. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
[TBL] [Abstract][Full Text] [Related]
3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
4. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].
Huang XY; Wu J; Liu ZB; Zhang JX; Han QX; Xu WP; Ping B; Yang WT; Shen ZZ; Shao ZM
Ai Zheng; 2007 Oct; 26(10):1133-7. PubMed ID: 17927887
[TBL] [Abstract][Full Text] [Related]
5. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.
Nour A
Breast J; 2004; 10(5):388-91. PubMed ID: 15327490
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Tanaka Y; Maeda H; Ogawa Y; Nishioka A; Itoh S; Kubota K; Ue H; Nakatani K; Sasaguri S
Oncol Rep; 2006 Apr; 15(4):927-31. PubMed ID: 16525681
[TBL] [Abstract][Full Text] [Related]
9. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
10. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
12. Breast sentinel lymph node dissection before preoperative chemotherapy.
Grube BJ; Christy CJ; Black D; Martel M; Harris L; Weidhaas J; Digiovanna MP; Chung G; Abu-Khalaf MM; Miller KD; Higgins SA; Philpotts L; Tavassoli FA; Lannin DR
Arch Surg; 2008 Jul; 143(7):692-9; discussion 699-700. PubMed ID: 18645113
[TBL] [Abstract][Full Text] [Related]
13. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
Golshan M; Nakhlis F
Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of mastoscopic axillary sentinel lymph node biopsy].
Zhang J; Luo CY; Lin H; Xue L; Yang Q; Huang X; Zou RC; Zhang ZB; Zhou YQ; Ding Y; Pan BJ; Zhang SH; Li J
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):799-801. PubMed ID: 15363299
[TBL] [Abstract][Full Text] [Related]
15. The role of sentinel lymph-node biopsy (SLNB) in the treatment of breast cancer.
Marrazzo A; Taormina P; David M; Casà L; Lo Gerfo D; Noto A; Riili I; Ficola U; Russo L
Chir Ital; 2006; 58(3):299-304. PubMed ID: 16845865
[TBL] [Abstract][Full Text] [Related]
16. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
17. Blue-dye intraoperative sentinel lymph node mapping in early non-small cell lung cancer.
Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe MI; Paleczka W; Murawski M; Jastrzebski T; Kopacz A; Jassem J; Skokowski J
Eur J Surg Oncol; 2006 May; 32(4):462-5. PubMed ID: 16504458
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
Newman EA; Cimmino VM; Sabel MS; Diehl KM; Frey KA; Chang AE; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):52-7. PubMed ID: 16372155
[TBL] [Abstract][Full Text] [Related]
19. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
